Fundraising Fox

Daniella Kranjac

Investor

General Partner at Avant Bio Β· Founding Partner at Dynamk Capital Β· Board director at RoosterBio

New York, New York

Writes $3M – $10M checks Β· typically $5M

About

Senior figure at AVANT BIO, featured in 100 Women in Finance's profile series and nominated as an INNOVATE100 honoree.

ContactΒ· self-published, not guessed

Board director at RoosterBio

Intro paths

β†’

In turn, Daniella can intro founders to RoosterBio's investors below.

Co-founders at RoosterBio

JRJon Rowley
Jon RowleyDirector

Experience

  1. Avant Bio LLCFounding GPcurrent2023 β€” presentNew York City Metropolitan Area
  2. Alpenglow BiosciencesBoard Membercurrent2023 β€” present
  3. CellFEBoard Membercurrent2022 β€” present
  4. Curi BioBoard Membercurrent2023 β€” present
  5. EnvisagenicsInvestor / Board Observer (2016-2022)current2017 β€” presentNew York City Metropolitan Area
  6. Intrepid LabsBoard Observercurrent2025 β€” presentToronto, Ontario, Canada
  7. RoosterBio Inc.Board Membercurrent2019 β€” present
  8. Virica BiotechBoard Membercurrent2021 β€” presentOttawa, Ontario, Canada
  9. Xcell BiosciencesBoard Observercurrent2021 β€” presentSan Francisco Bay Area
  10. Dynamk Consulting LLCFounder & CEOcurrent2015 β€” presentNew Jersey, USA
  11. Dynamk CapitalFounding Partnercurrent2017 β€” presentNew York City Metropolitan Area
  12. Global Women in VCMembercurrent2020 β€” present
  13. Vernal BiosciencesBoard Member2023 β€” 2025
  14. FloDesign SonicsBoard Member2017 β€” 2019
  15. GE HealthcareGlobal Head, Enterprise Solutions2014 β€” 2015Global virtual team: USA, Europe, Brazil, Australia, China, Singapore
  16. GE HealthcareHead of Business Development2013 β€” 2014Americas, Europe, Middle East
  17. GE HealthcareEnterprise Solutions Business Development2010 β€” 2013North America, Brazil & Latin America
  18. GE HealthcareIntegration Leader and Head, Commercial Operations2007 β€” 2010
  19. Wave Biotech LLCCo-Founder, Vice President1999 β€” 2007

Skills & more

Strategy99Management41Leadership36Biotechnology99Life Sciences77Start-ups70Business Development67Mergers & Acquisitions27Biopharmaceuticals36Product Management36Commercialization31Entrepreneurship24
+6 moreTechnology TransferMarketing StrategyGMPProduct DevelopmentCross-functional Team LeadershipPharmaceutical Industry

Languages Croatian

From Daniella's professional profile.

Deals Β· 4

ALPENGLOW BIOSCIENCES, INC.Board seat

via Avant Bio Β· filed Dec 2025 Β· $3M raise

RoosterBioBoard seat

via Avant Bio Β· filed Jul 2024 Β· $12M raise

ViricaBoard seat

via Avant Bio Β· filed May 2024

Vernal BiosciencesBoard seat

via Avant Bio Β· filed Jun 2023 Β· $41M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Avant Bio

Network5

Investors connected to Daniella in public investor directories β€” a warm-intro map.

Frequently asked questions

Who is Daniella Kranjac?
Senior figure at AVANT BIO, featured in 100 Women in Finance's profile series and nominated as an INNOVATE100 honoree.
Where does Daniella Kranjac work?
Daniella Kranjac is General Partner at Avant Bio and Board director at RoosterBio.
What check size does Daniella Kranjac write?
Daniella Kranjac typically writes checks of $3M – $10M.
What boards does Daniella Kranjac sit on?
Daniella Kranjac holds tracked board seats at ALPENGLOW BIOSCIENCES, INC., RoosterBio, Vernal Biosciences, Virica.
Where did Daniella Kranjac go to school?
Daniella Kranjac studied at NYU Stern School of Business (Executive MBA); Harvard Business School (Executive Education, Private Equity and Venture Capital); Columbia Business School (Executive Education Program, Finance and Accounting for the non-Financial Executive).

Same school

Shared employers